Prophylactic effects of probiotic Bifidobacterium spp. in the resolution of inflammation in arthritic rats.

In the present study, the modulatory effects of bifidobacterial spp. (Bifidobacterium breve NCIM 5671, Bifidobacterium longum NCIM
5672 and Bifidobacterium bifidum NCIM 5697) on adjuvant induced arthritis in rats were evaluated. Arthritis was induced in male
Wistar rats by injecting 250 μg of Freund’s adjuvant directly into the paw. Fifteen days before and 15 days after the induction of arthritis,
suspended cultures of bifidobacteria (109 cfu/ml) were administered by oral gavage. Paw volume, bone mineral content, oxidative stress
markers, antioxidant enzymes, cytokines, eicosanoids and expression of COX2, as well as bone hydrolytic enzymes, were assessed by
RT PCR. Although piroxicam-treated groups (drug control) had better effects than bifidobacteria-treated groups, bifidobacteria
probiotics administration exhibited significant (P < 0.05) prophylactic effects in terms of downregulating arthritis markers.
Parameters including paw volume, bone mineral content, cytokines, and eicosanoids level were significantly (p < 0.05) modulated in
bifidobacteria administered groups compared to arthritic control group. Among the three strains tested, B. breve NCIM 5671 exhibited
superior prophylactic effects as assessed in the experimental rat model of arthritis. In conclusion, bifidobacteria probiotics administration
can downregulate the markers of arthritis and hence can be a potential therapeutic regimen in the treatment of arthritis.